Full Title
A Phase III, Multicentre, Randomised Controlled Study to Evaluate the Efficacy and Safety of AZD2265 (FPI-2265) 225Ac-PSMA-I and T Compared With Standard of Care in Patients with PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)Purpose
To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.
Contact
For more information or to see if you can join this study, please call Dr. Michael Morris’s office at 646-422-4469.
Protocol
26-290
Phase
Phase III (phase 3)
Disease Status
Relapsed or Refractory
Investigator
Co-Investigators
Diseases
Locations
ClinicalTrials.gov ID
NCT07611110
ClinicalTrials.gov